Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS)

NCT06055881 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06055881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06055881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy (BOSS)
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 23, 2023
Completion date
August 6, 2031
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage iv breast cancer ajcc v8, breast carcinoma, metastatic breast cancer